This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 "Tackling diseases and reducing disease burden". The partnership will be firmly anchored within the framework of the European Health Union package[1] that aims to improve the EU's capacity in the vital areas of prevention, preparedness, surveillance, risk assessment, early warning, and response. In this regard, synergies and close collaboration with the European Health Emergency Preparedness and Response Authority (HERA) and other relevant European Commission services need to be ensured.
The partnership's activities are expected to be key enablers of the EU Global Health Strategy[2], notably its guiding principle 5 to boost global health research and guiding principle 7 to strengthen capacities for prevention, preparedness and response, particularly to expand and strengthen European and global research partnerships including clinical trial networks that can be pivoted to address new and emerging pathogens.
Proposals under this topic should aim for delivering results that are directed, tailored towards, and contributing to all of the following expected outcomes:
- The EU offers a valued network of clinical trial sites that have the capacity to implement well-coordinated large-scale multi-country quality trials in different target populations, which are able to
